CLINICAL_TRIALS
research
· 2024-05-29
Clinical Trial Update: Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome [NA]
Summary
This clinical trial update describes a study investigating triggers and risk factors for developing reversible cerebral vasoconstriction syndrome. The trial is …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Montpellier | Conditions: Reversible Cerebral Vasoconstriction Syndrome | NA | Status: RECRUITING